Rare diseases
Investigational molecules
Locations
Back to France971 clinical trials in Nice, France across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on ABCB5+ MSCs for Recessive Dystrophic and Junctional Epidermolysis Bullosa Patients
FranceAssessing the efficacy and safety of nemolizumab in patients aged 12 years or older with dystrophic epidermolysis bullosa
FranceStudy of epcoritamab, venetoclax and ibrutinib in treatment‑naïve chronic lymphocytic leukemia patients with TP53 alterations
FranceSafety and efficacy of efimosfermin alfa versus placebo in adults with compensated cirrhosis (stage F4) due to MASH
FranceFranceStudy of efimosfermin alfa versus placebo in adults with compensated cirrhosis from metabolic dysfunction-associated steatohepatitis (MASH)
FrancePhase II trial evaluating trastuzumab deruxtecan in patients with HER2‑positive advanced/metastatic cancer
FranceEfficacy of daily high‑dose sulfamethoxazole‑trimethoprim prophylaxis versus low‑dose on bacterial infections in kidney transplant recipients
FranceStudy of Elritercept (TAK‑226) with Ruxolitinib vs Placebo in Patients with Myelofibrosis and Anemia on Ruxolitinib Therapy
FranceStudy of ATX-898 alone and in drug combination for patients with advanced solid tumors
FrancePrecision Monitoring of Tacrolimus and Mycophenolate Mofetil in Adult Liver Transplant Recipients: Randomized Controlled Trial
FrancePharmacokinetic study of pembrolizumab and drug combination in patients with non‑small cell lung cancer or head and neck squamous cell carcinoma
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on neurodegenerative conditions and movement disorders, including trials evaluating new treatments for Amyotrophic Lateral Sclerosis and Essential Tremor.
Studies aim to improve quality of life and slow disease progression through targeted therapeutic approaches.
Comprehensive research into inflammatory disorders, including studies on Psoriatic Arthritis and innovative treatments for various autoimmune conditions.
Focus on developing targeted therapies and combination treatments for better disease control.
Advanced studies in cancer treatment, particularly focusing on head and neck cancers and innovative approaches in lung cancer therapy.
Investigating combination therapies and targeted treatments for improved patient outcomes.
Groundbreaking research in inflammatory bowel diseases, including novel approaches for Crohn's Disease and Ulcerative Colitis treatment.
Exploring innovative therapeutic strategies and microbiome-based treatments.
Critical research in HIV prevention and treatment, focusing on long-acting preventive medications and innovative therapeutic approaches.
Development of new preventive measures and treatment options for at-risk populations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
